R. Erik Holmlin - 14 Mar 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
14 Mar 2025
Net transactions value
-$687
Form type
4
Filing time
18 Mar 2025, 18:45:35 UTC
Previous filing
19 Feb 2025
Next filing
03 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Tax liability $687 -198 -10% $3.47 1,783 14 Mar 2025 Direct F1
holding BNGO Common Stock 8 14 Mar 2025 Robert Erik Holmlin Traditional IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +17,449 $0.000000 17,449 14 Mar 2025 Common Stock 17,449 $3.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award.
F2 Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date.